scholarly journals Survival benefit from immunocheckpoint inhibitors in stage IV non‐small cell lung cancer patients with brain metastases: A National Cancer Database propensity‐matched analysis

2020 ◽  
Author(s):  
Shinkichi Takamori ◽  
Takefumi Komiya ◽  
Emily Powell
Sign in / Sign up

Export Citation Format

Share Document